| 标题： | 中成药治疗成人咳嗽循证临床指南 |
| title： | Clinical practice guideline on treating cough in adult patients with Chinese patent medicines |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 中医药指南 |
| classification： | Traditional Chinese Medicine guideline |
| 领域： | 治疗 |
| field： | Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 本指南可适用于治疗慢性咳嗽、亚急性咳嗽、急性咳嗽类疾病的医务人员、公共卫生人员、科研工作者及患以上三类的咳嗽的患者。 |
| Guide users： | This guideline can be applied to medical personnel, public health personnel, scientific research workers who treat chronic cough, subacute cough and acute cough diseases, as well as patients suffering from the above three types of cough. |
| 证据分级方法： | We will import the evidence of Chinese patent medicine for treating adult cough into the GRADE system, conduct a summary evaluation of the certainty of the evidence, make a summary table of evidence, and form a list of recommended opinion items. GRADE approach provides a method for evaluating the certainty of the evidence and strength of recommendations for the clinical practice guideline. GRADE approach based on risk of bias, inconsistency, indirectness, publication bias, and imprecision. We will use GRADE approach to formulate the recommendations and categorized the strength of recommendations as “strong” and “weak” by comprehensively considering the balance of benefits and harms, the certainty of evidence, cost, clinical feasibility, accessibility, and clinical acceptability. |
| Evidence grading method： | |
| 制定单位： | 兰州大学；广东省中医院 |
| Formulating unit： | Lanzhou University；Traditional Chinese Medicine Hospital of Guangdong Province |
| 注册时间： | 2021-05-10 |
| Registration time： | |
| 注册编号： | IPGRP-2021CN107 |
| Registration number： | |
| 指南制订的目的： | 咳嗽是呼吸专科门诊和社区门诊患者最常见的症状，具有高发病率、严重影响生活质量、患者治疗需求量高的特点。美国每年有约3000万因咳嗽就诊的患者，在我国专科门诊中，慢性咳嗽患者数量约占三分之一。治疗成人咳嗽存在误用、滥用抗生素及镇咳药的现象，易造成耐药性、成瘾性，诱发一系列不良反应。中医药通过“辨证论治”，在缓解症状、改善生活质量、减少复发方面有一定优势，其中中成药因便于携带和服用而应用较广。我国2015年发布的《咳嗽的诊断与治疗指南》中，首次将中医治疗加入指南，提示中医药治疗咳嗽的疗效已开始得到认可。但目前市场上治疗咳嗽的中成药种类繁多，在临床运用中普遍存在不科学、不合理的现象，同时也缺乏专门的中成药治疗成人咳嗽的临床循证指南供遵循和参考，在一定程度上影响了临床疗效。因此，制定“中成药治疗成人咳嗽的临床应用指南”，以规范临床治疗，推广应用，提高中成药治疗成人咳嗽的水平。 |
| Purpose of the guideline： | Cough is the most common symptom of patients in respiratory specialist clinics and community clinics. It has the characteristics of high morbidity, serious impact on the quality of life, and high demand for treatment. There are about 30 million cough patients in the United States every year, and chronic cough patients account for about one third of the specialist outpatients in China. Currently, there is widespread misuse and abuse of antibiotics and antitussives in the treatment of cough. Traditional Chinese medicine (TCM) has certain advantages in relieving symptoms, improving quality of life, and reducing recurrence through "syndrome differentiation and treatment". Among them, Chinese patent medicines are widely used because they are easy to carry and take. In 2015, the "Guideline for the Diagnosis and Treatment of Cough" was published in China, and TCM treatment was added to this guideline for the first time, suggesting that the efficacy of TCM for the treatment of cough has begun to be recognized. However, currently there are many types of Chinese patent medicines for the treatment of cough, and there are widespread unscientific and unreasonable phenomena in clinical application. At the same time, there is also a lack of clinical evidence-based guideline for the treatment of adult cough with Chinese patent medicines. To a certain extent, the above factors affect the clinical effect. Therefore, the " Clinical practice guideline on treating cough in adult patients with Chinese patent medicines " were formulated to standardize clinical treatment, promote the application, and improve the level of Chinese patent medicines in the treatment of adult cough. |
